Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

Jupiter Medical Center Named “Best Hospital,” “Best Place to Have a Baby,” and “Best Emergency Room” in Palm Beach County

“We are thrilled that the residents of our Palm Beach County have chosen to show their appreciation for Jupiter Medical Center and the world-class care provided by our team members,” said Dr. Amit Rastogi, president and CEO of Jupiter Medical Center. “Patients and consumers have a lot of choices for health care in Palm Beach County and throughout the Treasure Coast. We are honored to be singled out by them as the ‘Best Hospital,’ ‘Best Place to Have a Baby,’ and ‘Best Emergency Room (ER).’ We appreciate the trust our community has placed in us.”

Best of Palm Beach County Awards – Best Hospital
Equipped with state-of-the-art technology and staffed by an experienced team dedicated to providing clinical excellence and cultivating a culture of compassion, Jupiter Medical Center consistently has the highest patient satisfaction scores in the region. The Best of Palm Beach County awards follow several national recognitions Jupiter Medical Center has recently received. Jupiter Medical Center is the only hospital in Palm Beach County to receive a 4-star quality and safety rating from the Centers for Medicare & Medicaid Services (CMS). The Leapfrog Group has also named Jupiter Medical Center a “Top Hospital,” placing Jupiter Medical Center in the top 6 percent of hospitals nationwide.

Jupiter Medical Center continues to significantly expand treatment options for patients with the recently announced affiliation between the Anderson Family Cancer Institute and Sylvester Comprehensive Cancer Center at the University of Miami Leonard M. Miller School of Medicine, providing residents of Palm Beach County and the Treasure Coast with seamless access to groundbreaking cancer treatments.

Best of Palm Beach County Awards – Best Place to Have a Baby
Each year, more than 1,600 babies are delivered in Jupiter Medical Center’s Florence A. De George Children & Women’s Services Obstetrics Unit. The unit recently added the Level II De George Neonatal Intensive Care Unit (NICU), which is equipped to care for babies born as early as 32 weeks.

“Our obstetrics unit is staffed by experienced neonatal specialists and equipped with the latest technology to ensure mom, baby, and family are thriving before, during and after delivery,” said Pam Canter, interim chief nursing officer. “And with the addition of our new NICU, we now have the ability to care for preemies or seriously ill newborns who require a higher level of specialized attention.”

Best of Palm Beach County Awards – Best Emergency Room
Jupiter Medical Center’s emergency department is ready 24/7 to provide life-saving care to patients with critical conditions and other urgent medical issues. In 2019, Jupiter Medical Center expanded our specialized pediatric emergency capabilities with the opening of the Mastroianni Family Pediatric Emergency Department. This dedicated, child-friendly space has eight beds and is designed to be calming and reassuring to younger patients.

“Last year, we saw nearly 40,000 visits to the emergency department at Jupiter Medical Center,” said Carol Milliken, director of the emergency department. “The addition of the Mastroianni Family Pediatric Emergency Department allows us to provide our young patients with their own waiting area, triage rooms and treatment rooms, where they are cared for by our pediatric emergency teams.”

“2020 is a time of historic growth and development for Jupiter Medical Center,” added Dr. Rastogi. “We are introducing groundbreaking new treatments and capabilities to the residents of Palm Beach County and the Treasure Coast, as we continue our evolution to becoming a regional health care destination. Being recognized by the community we serve for our unwavering commitment to excellence, quality and patient experience is truly gratifying.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

4SC Receives Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from the US FDA

Jason Loveridge, Ph.D., CEO of 4SC, commented: “Receiving orphan drug designation for resminostat provides us with a number of important benefits, most crucially 7 years’ market exclusivity in the US, a key foundation of our efforts to commercialise Kinselby.  We are currently preparing a marketing authorisation application for Kinselby in the EU, which remains on track for submission in Q1 2024.”

Abyrx Receives FDA Clearance for MONTAGE ® Settable Bone Putty for Use in Cardiothoracic Surgery

By expanding the range of FDA-cleared surgical applications for MONTAGE, this latest milestone positions Abyrx to build upon the more than 25,000 units of MONTAGE that have been used to date by surgeons in trauma, orthopedics, sports medicine, foot and ankle, and craniomaxillofacial procedures.

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

By using this website you agree to accept Medical Device News Magazine Privacy Policy